Browsing Tag
Losartan Potassium
2 posts
BlinkRx collaboration positions Scienture’s Arbli for nationwide patient access in the $250+ million losartan market
Discover how Scienture and BlinkRx are expanding nationwide access to Arbli, the first FDA-approved liquid losartan, and what it means for the $250M hypertension market.
December 10, 2025
Scienture starts commercial rollout of Arbli, the first FDA-approved losartan oral suspension
Find out how Scienture is changing the hypertension treatment market with the FDA-approved Arbli losartan oral suspension.
October 23, 2025